Description
There is an arising interest on premalignant lesions: the malignant transformation pathways need to be better elucidated, as well as the predictive factors must be implemented, so to offer a better knowledge of the preclinical aspects of this disease. Similarly, the clinical aspects of OPMDs need to be studied, as at the moment no approved and efficacious preventive treatment is available. Therefore, OPMDs offer interesting landscapes for a multidisciplinary approach involving biomolecular experts, pathologists, surgeons, medical oncologists, pharmacologists, as well as experts in design of clinical trials.Keynote Lectures will deal with pathological, molecular and clinical issues,
suggesting a strict integration with the aim to investigate new fields of research
and transpose the latest findings into practice. Moreover, a round table on ethical issues and an overview about next steps to implement research is scheduled. An appropriate time will be dedicated to the presentation of abstract and ongoing research on OPMDs, so to offer the possibility to present the latest research and to receive feedback, so to increase the cooperation with other research groups.
| Periode | 25-feb.-2022 |
|---|---|
| Evenementstype | Conference |
| Locatie | Brescia, ItalyToon op kaart |
| Mate van erkenning | International |